North America Pain Management Devices Market By Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices) By Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
The North America Pain Management Devices Market would witness market growth of 7.9% CAGR during the forecast period (2020-2026).
Pain is an unpleasant sensory and emotional experience caused by damage or disease to the tissues. It is caused by injury and a variety of diseases including osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer, fibromyalgia, and cancer. It can be classified as acute pain and chronic pain based on duration. Acute pain is a rapid occurrence of pain where it lasts for long stretches as persistent pain. Chronic pain is triggered mainly by aging bone and joint problems, including nerve damage and injuries.
Pain is managed by a particular set of pain treatment medicines or devices. The pain management systems include transcutaneous electrical nerve stimulators, neuro-stimulators, analgesic infusion pumps, and radiofrequency ablators. Most of these devices block the mechanism of the pain gate, to prevent the passage of pain signals to the brain.
Radiofrequency ablators destroy nerves by generating heat to suppress pain signals. Similarly, neuro-stimulator devices use mild current frequencies that prevent pain signals from passing in. These devices help in treating various painful conditions such as cancer, musculoskeletal injury, and neuropathic pain. Pain control tools help reduce the risk of long-term narcotics, non-steroidal anti-inflammatory medicines, and other medications that ease discomfort.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Study
Market Segmentation:
By Product
Pain is an unpleasant sensory and emotional experience caused by damage or disease to the tissues. It is caused by injury and a variety of diseases including osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer, fibromyalgia, and cancer. It can be classified as acute pain and chronic pain based on duration. Acute pain is a rapid occurrence of pain where it lasts for long stretches as persistent pain. Chronic pain is triggered mainly by aging bone and joint problems, including nerve damage and injuries.
Pain is managed by a particular set of pain treatment medicines or devices. The pain management systems include transcutaneous electrical nerve stimulators, neuro-stimulators, analgesic infusion pumps, and radiofrequency ablators. Most of these devices block the mechanism of the pain gate, to prevent the passage of pain signals to the brain.
Radiofrequency ablators destroy nerves by generating heat to suppress pain signals. Similarly, neuro-stimulator devices use mild current frequencies that prevent pain signals from passing in. These devices help in treating various painful conditions such as cancer, musculoskeletal injury, and neuropathic pain. Pain control tools help reduce the risk of long-term narcotics, non-steroidal anti-inflammatory medicines, and other medications that ease discomfort.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Study
Market Segmentation:
By Product
- Neuromodulation & Neurostimulation Devices
- Analgesic Infusion Pumps and
- Ablation Devices
- Neuropathic Pain
- Musculoskeletal Pain
- Cancer Pain
- Facial & Migraine Pain and
- Other Applications
- US
- Canada
- Mexico
- Rest of North America
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- Kimberly-Clark Corporation
- Stryker Corporation
- Colfax Corporation (DJO Global, Inc.)
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pain Management Devices Market, by Product
1.4.2 North America Pain Management Devices Market, by Application
1.4.3 North America Pain Management Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT
4.1 North America Neuromodulation & Neurostimulation Devices Market by Country
4.2 North America Analgesic Infusion Pumps Market by Country
4.3 North America Ablation Devices Market by Country
CHAPTER 5. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION
5.1 North America Neuropathic Pain Market by Country
5.2 North America Musculoskeletal Pain Market by Country
5.3 North America Cancer Pain Market by Country
5.4 North America Facial & Migraine Pain Market by Country
5.5 North America Other Applications Market by Country
CHAPTER 6. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY
6.1 US Pain Management Devices Market
6.1.1 US Pain Management Devices Market by Product
6.1.2 US Pain Management Devices Market by Application
6.2 Canada Pain Management Devices Market
6.2.1 Canada Pain Management Devices Market by Product
6.2.2 Canada Pain Management Devices Market by Application
6.3 Mexico Pain Management Devices Market
6.3.1 Mexico Pain Management Devices Market by Product
6.3.2 Mexico Pain Management Devices Market by Application
6.4 Rest of North America Pain Management Devices Market
6.4.1 Rest of North America Pain Management Devices Market by Product
6.4.2 Rest of North America Pain Management Devices Market by Application
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expense
7.3 Baxter International, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Boston Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 Johnson and Johnson
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition and Mergers:
7.7 Medtronic PLC
7.7.1 Company overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Approvals:
7.7.5.3 Acquisition and Mergers:
7.7.5.4 Product Launches and Product Expansions:
7.8 Kimberly-Clark Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Stryker Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 Colfax Corporation (DJO Global, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pain Management Devices Market, by Product
1.4.2 North America Pain Management Devices Market, by Application
1.4.3 North America Pain Management Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT
4.1 North America Neuromodulation & Neurostimulation Devices Market by Country
4.2 North America Analgesic Infusion Pumps Market by Country
4.3 North America Ablation Devices Market by Country
CHAPTER 5. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION
5.1 North America Neuropathic Pain Market by Country
5.2 North America Musculoskeletal Pain Market by Country
5.3 North America Cancer Pain Market by Country
5.4 North America Facial & Migraine Pain Market by Country
5.5 North America Other Applications Market by Country
CHAPTER 6. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY
6.1 US Pain Management Devices Market
6.1.1 US Pain Management Devices Market by Product
6.1.2 US Pain Management Devices Market by Application
6.2 Canada Pain Management Devices Market
6.2.1 Canada Pain Management Devices Market by Product
6.2.2 Canada Pain Management Devices Market by Application
6.3 Mexico Pain Management Devices Market
6.3.1 Mexico Pain Management Devices Market by Product
6.3.2 Mexico Pain Management Devices Market by Application
6.4 Rest of North America Pain Management Devices Market
6.4.1 Rest of North America Pain Management Devices Market by Product
6.4.2 Rest of North America Pain Management Devices Market by Application
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expense
7.3 Baxter International, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Boston Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 Johnson and Johnson
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition and Mergers:
7.7 Medtronic PLC
7.7.1 Company overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Approvals:
7.7.5.3 Acquisition and Mergers:
7.7.5.4 Product Launches and Product Expansions:
7.8 Kimberly-Clark Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Stryker Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 Colfax Corporation (DJO Global, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
LIST OF TABLES
TABLE 1 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– PAIN MANAGEMENT DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– PAIN MANAGEMENT DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – PAIN MANAGEMENT DEVICES MARKET
TABLE 6 APPROVALS – PAIN MANAGEMENT DEVICES MARKET
TABLE 7 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 8 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 9 NORTH AMERICA NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 NORTH AMERICA NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 NORTH AMERICA ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 NORTH AMERICA ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 NORTH AMERICA ABLATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 NORTH AMERICA ABLATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 16 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 17 NORTH AMERICA NEUROPATHIC PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 NORTH AMERICA NEUROPATHIC PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 NORTH AMERICA MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 NORTH AMERICA MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 NORTH AMERICA CANCER PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 NORTH AMERICA CANCER PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 NORTH AMERICA FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 NORTH AMERICA FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 US PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 30 US PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 31 US PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 32 US PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 33 US PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 34 US PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 35 CANADA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 CANADA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 CANADA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 38 CANADA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 39 CANADA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 40 CANADA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 41 MEXICO PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 MEXICO PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 MEXICO PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 44 MEXICO PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 45 MEXICO PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 46 MEXICO PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 47 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 50 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 51 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 52 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 53 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 54 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 55 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 56 KEY INFORMATION – PFIZER, INC.
TABLE 57 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 58 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 59 KEY INFORMATION – MEDTRONIC PLC
TABLE 60 KEY INFORMATION – KIMBERLY-CLARK CORPORATION
TABLE 61 KEY INFORMATION – STRYKER CORPORATION
TABLE 62 KEY INFORMATION – COLFAX CORPORATION
TABLE 1 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– PAIN MANAGEMENT DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– PAIN MANAGEMENT DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – PAIN MANAGEMENT DEVICES MARKET
TABLE 6 APPROVALS – PAIN MANAGEMENT DEVICES MARKET
TABLE 7 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 8 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 9 NORTH AMERICA NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 NORTH AMERICA NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 NORTH AMERICA ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 NORTH AMERICA ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 NORTH AMERICA ABLATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 NORTH AMERICA ABLATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 16 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 17 NORTH AMERICA NEUROPATHIC PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 NORTH AMERICA NEUROPATHIC PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 NORTH AMERICA MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 NORTH AMERICA MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 NORTH AMERICA CANCER PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 NORTH AMERICA CANCER PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 NORTH AMERICA FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 NORTH AMERICA FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 US PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 30 US PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 31 US PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 32 US PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 33 US PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 34 US PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 35 CANADA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 CANADA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 CANADA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 38 CANADA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 39 CANADA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 40 CANADA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 41 MEXICO PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 MEXICO PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 MEXICO PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 44 MEXICO PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 45 MEXICO PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 46 MEXICO PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 47 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 50 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 51 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 52 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 53 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 54 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 55 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 56 KEY INFORMATION – PFIZER, INC.
TABLE 57 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 58 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 59 KEY INFORMATION – MEDTRONIC PLC
TABLE 60 KEY INFORMATION – KIMBERLY-CLARK CORPORATION
TABLE 61 KEY INFORMATION – STRYKER CORPORATION
TABLE 62 KEY INFORMATION – COLFAX CORPORATION
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENT: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENT: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
